Results 91 to 100 of about 4,616 (237)
The pathology of medication-related osteonecrosis of the jaw (MRONJ), often associated with antiresorptive therapy, is still not fully understood. Osteocyte networks are known to play a critical role in maintaining bone homeostasis and repair, but the ...
Anh Tuan Dang +9 more
semanticscholar +1 more source
Pharmacology: MRONJ risk factor [PDF]
D, Patel, V, Patel
openaire +2 more sources
New Perspective for Soft Tissue Closure in Medication-Related Osteonecrosis of the Jaw (MRONJ) Using Barbed Sutures [PDF]
Johannes Laimer +7 more
openalex +1 more source
OBJECTIVES Anti-resorptive agents have been linked to the development of MRONJ in patients undergoing dental surgical procedures. This survey aims to explore the level of knowledge and experience of Italian Society of Periodontology and Implantology ...
L. Landi +10 more
semanticscholar +1 more source
Medication Related Osteonecrosis of the Jaw (MRONJ). Review and recent advances [PDF]
Dimitra Galiti +3 more
openalex +1 more source
Background: Medication-related osteonecrosis of the jaws is the most frequent complication in patients treated or in therapy with antiresorptive/antiangiogenetic drugs.
Marta Forte +7 more
semanticscholar +1 more source
Medication-related osteonecrosis of the jaw (MRONJ) is a relatively rare but serious pathology associated with the use of bisphosphonates (BPs) and antiresorptive drugs in patients with bone metastases, multiple myeloma and osteoporosis. Various cases of
Mihaylova Z. +3 more
doaj +1 more source

